Sutro Biopharma (NASDAQ:STRO) Rating Reiterated by Wedbush
Sutro Biopharma (NASDAQ:STRO – Get Free Report)‘s stock had its “outperform” rating restated by analysts at Wedbush in a research report issued on Tuesday, Benzinga reports. They presently have a $8.00 price target on the stock. Wedbush’s target price suggests a potential upside of 103.56% from the stock’s previous close. Several other equities analysts have […]
More Stories
Valuence Merger Corp. I (VMCA) & Its Rivals Financial Review
Volatility and Risk Valuence Merger Corp. I has a beta of 0.01, indicating that its stock price is 99% less...
Russia Will Help China Advance Submarine Technology, US Indo-Pacific Commander Says
By Frank Fang In return for China’s support during its war on Ukraine, Russia will likely assist Beijing to advance...
Financial Contrast: Carnival Co. & (NYSE:CUK) versus Viking (NYSE:VIK)
Viking (NYSE:VIK – Get Free Report) and Carnival Co. & (NYSE:CUK – Get Free Report) are both transportation companies, but...
Centaurus Financial Inc. Lowers Stock Holdings in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH)
Centaurus Financial Inc. cut its stake in shares of iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH – Free Report) by 2.5%...
PepsiCo, Inc. (NASDAQ:PEP) Shares Purchased by Summit Trail Advisors LLC
Summit Trail Advisors LLC increased its position in shares of PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 18.3% during the...
Costco Wholesale Co. (NASDAQ:COST) Shares Acquired by Daiwa Securities Group Inc.
Daiwa Securities Group Inc. boosted its stake in Costco Wholesale Co. (NASDAQ:COST – Free Report) by 19.0% in the third...